P2X7 Receptor Antagonists Market, Global Outlook and Forecast 2023-2028

Report ID: 1372696 | Published Date: Jan 2025 | No. of Page: 63 | Base Year: 2024 | Rating: 4.8 | Webstory: Check our Web story
Request Sample Report
Pre-Order Enquiry
Request Discount(%) 
1 Introduction to Research & Analysis Reports
    1.1 P2X7 Receptor Antagonists Market Definition
    1.2 Market Segments
        1.2.1 Market by Type
        1.2.2 Market by Application
    1.3 Global P2X7 Receptor Antagonists Market Overview
    1.4 Features & Benefits of This Report
    1.5 Methodology & Sources of Information
        1.5.1 Research Methodology
        1.5.2 Research Process
        1.5.3 Base Year
        1.5.4 Report Assumptions & Caveats
2 Global P2X7 Receptor Antagonists Overall Market Size
    2.1 Global P2X7 Receptor Antagonists Market Size: 2021 VS 2028
    2.2 Global P2X7 Receptor Antagonists Market Size, Prospects & Forecasts: 2017-2028
    2.3 Key Market Trends, Opportunity, Drivers and Restraints
        2.3.1 Market Opportunities & Trends
        2.3.2 Market Drivers
        2.3.3 Market Restraints
3 Company Landscape
    3.1 Top P2X7 Receptor Antagonists Players in Global Market
    3.2 Top Global P2X7 Receptor Antagonists Companies Ranked by Revenue
    3.3 Global P2X7 Receptor Antagonists Revenue by Companies
    3.4 Top 3 and Top 5 P2X7 Receptor Antagonists Companies in Global Market, by Revenue in 2021
    3.5 Global Companies P2X7 Receptor Antagonists Product Type
    3.6 Tier 1, Tier 2 and Tier 3 P2X7 Receptor Antagonists Players in Global Market
        3.6.1 List of Global Tier 1 P2X7 Receptor Antagonists Companies
        3.6.2 List of Global Tier 2 and Tier 3 P2X7 Receptor Antagonists Companies
4 Market Sights by Product
    4.1 Overview
        4.1.1 by Type - Global P2X7 Receptor Antagonists Market Size Markets, 2021 & 2028
        4.1.2 GSK1482160
        4.1.3 AZD9056
        4.1.4 EVT 401
        4.1.5 JNJ 55308942 & JNJ 54175446
        4.1.6 AKP-23494954/RQ-00466479
        4.1.7 Others
    4.2 By Type - Global P2X7 Receptor Antagonists Revenue & Forecasts
        4.2.1 By Type - Global P2X7 Receptor Antagonists Revenue, 2017-2022
        4.2.2 By Type - Global P2X7 Receptor Antagonists Revenue, 2023-2028
        4.2.3 By Type - Global P2X7 Receptor Antagonists Revenue Market Share, 2017-2028
5 Sights by Application
    5.1 Overview
        5.1.1 By Application - Global P2X7 Receptor Antagonists Market Size, 2021 & 2028
        5.1.2 Inflammatory Diseases
        5.1.3 Central Nervous System Diseases
        5.1.4 Immune System Disorders
    5.2 By Application - Global P2X7 Receptor Antagonists Revenue & Forecasts
        5.2.1 By Application - Global P2X7 Receptor Antagonists Revenue, 2017-2022
        5.2.2 By Application - Global P2X7 Receptor Antagonists Revenue, 2023-2028
        5.2.3 By Application - Global P2X7 Receptor Antagonists Revenue Market Share, 2017-2028
6 Sights by Region
    6.1 By Region - Global P2X7 Receptor Antagonists Market Size, 2021 & 2028
    6.2 By Region - Global P2X7 Receptor Antagonists Revenue & Forecasts
        6.2.1 By Region - Global P2X7 Receptor Antagonists Revenue, 2017-2022
        6.2.2 By Region - Global P2X7 Receptor Antagonists Revenue, 2023-2028
        6.2.3 By Region - Global P2X7 Receptor Antagonists Revenue Market Share, 2017-2028
    6.3 North America
        6.3.1 By Country - North America P2X7 Receptor Antagonists Revenue, 2017-2028
        6.3.2 US P2X7 Receptor Antagonists Market Size, 2017-2028
        6.3.3 Canada P2X7 Receptor Antagonists Market Size, 2017-2028
        6.3.4 Mexico P2X7 Receptor Antagonists Market Size, 2017-2028
    6.4 Europe
        6.4.1 By Country - Europe P2X7 Receptor Antagonists Revenue, 2017-2028
        6.4.2 Germany P2X7 Receptor Antagonists Market Size, 2017-2028
        6.4.3 France P2X7 Receptor Antagonists Market Size, 2017-2028
        6.4.4 U.K. P2X7 Receptor Antagonists Market Size, 2017-2028
        6.4.5 Italy P2X7 Receptor Antagonists Market Size, 2017-2028
        6.4.6 Russia P2X7 Receptor Antagonists Market Size, 2017-2028
        6.4.7 Nordic Countries P2X7 Receptor Antagonists Market Size, 2017-2028
        6.4.8 Benelux P2X7 Receptor Antagonists Market Size, 2017-2028
    6.5 Asia
        6.5.1 By Region - Asia P2X7 Receptor Antagonists Revenue, 2017-2028
        6.5.2 China P2X7 Receptor Antagonists Market Size, 2017-2028
        6.5.3 Japan P2X7 Receptor Antagonists Market Size, 2017-2028
        6.5.4 South Korea P2X7 Receptor Antagonists Market Size, 2017-2028
        6.5.5 Southeast Asia P2X7 Receptor Antagonists Market Size, 2017-2028
        6.5.6 India P2X7 Receptor Antagonists Market Size, 2017-2028
    6.6 South America
        6.6.1 By Country - South America P2X7 Receptor Antagonists Revenue, 2017-2028
        6.6.2 Brazil P2X7 Receptor Antagonists Market Size, 2017-2028
        6.6.3 Argentina P2X7 Receptor Antagonists Market Size, 2017-2028
    6.7 Middle East & Africa
        6.7.1 By Country - Middle East & Africa P2X7 Receptor Antagonists Revenue, 2017-2028
        6.7.2 Turkey P2X7 Receptor Antagonists Market Size, 2017-2028
        6.7.3 Israel P2X7 Receptor Antagonists Market Size, 2017-2028
        6.7.4 Saudi Arabia P2X7 Receptor Antagonists Market Size, 2017-2028
        6.7.5 UAE P2X7 Receptor Antagonists Market Size, 2017-2028
7 Players Profiles
    7.1 GlaxoSmithKline
        7.1.1 GlaxoSmithKline Corporate Summary
        7.1.2 GlaxoSmithKline Business Overview
        7.1.3 GlaxoSmithKline P2X7 Receptor Antagonists Major Product Offerings
        7.1.4 GlaxoSmithKline P2X7 Receptor Antagonists Revenue in Global Market (2017-2022)
        7.1.5 GlaxoSmithKline Key News
    7.2 AstraZeneca
        7.2.1 AstraZeneca Corporate Summary
        7.2.2 AstraZeneca Business Overview
        7.2.3 AstraZeneca P2X7 Receptor Antagonists Major Product Offerings
        7.2.4 AstraZeneca P2X7 Receptor Antagonists Revenue in Global Market (2017-2022)
        7.2.5 AstraZeneca Key News
    7.3 Janssen
        7.3.1 Janssen Corporate Summary
        7.3.2 Janssen Business Overview
        7.3.3 Janssen P2X7 Receptor Antagonists Major Product Offerings
        7.3.4 Janssen P2X7 Receptor Antagonists Revenue in Global Market (2017-2022)
        7.3.5 Janssen Key News
    7.4 RaQualia Pharma
        7.4.1 RaQualia Pharma Corporate Summary
        7.4.2 RaQualia Pharma Business Overview
        7.4.3 RaQualia Pharma P2X7 Receptor Antagonists Major Product Offerings
        7.4.4 RaQualia Pharma P2X7 Receptor Antagonists Revenue in Global Market (2017-2022)
        7.4.5 RaQualia Pharma Key News
    7.5 Evotec
        7.5.1 Evotec Corporate Summary
        7.5.2 Evotec Business Overview
        7.5.3 Evotec P2X7 Receptor Antagonists Major Product Offerings
        7.5.4 Evotec P2X7 Receptor Antagonists Revenue in Global Market (2017-2022)
        7.5.5 Evotec Key News
    7.6 Asahi Kasei Pharma
        7.6.1 Asahi Kasei Pharma Corporate Summary
        7.6.2 Asahi Kasei Pharma Business Overview
        7.6.3 Asahi Kasei Pharma P2X7 Receptor Antagonists Major Product Offerings
        7.6.4 Asahi Kasei Pharma P2X7 Receptor Antagonists Revenue in Global Market (2017-2022)
        7.6.5 Asahi Kasei Pharma Key News
    7.7 Pfizer
        7.7.1 Pfizer Corporate Summary
        7.7.2 Pfizer Business Overview
        7.7.3 Pfizer P2X7 Receptor Antagonists Major Product Offerings
        7.7.4 Pfizer P2X7 Receptor Antagonists Revenue in Global Market (2017-2022)
        7.7.5 Pfizer Key News
8 Conclusion
9 Appendix
    9.1 Note
    9.2 Examples of Clients
    9.3 Disclaimer

List of Tables
    Table 1. P2X7 Receptor Antagonists Market Opportunities & Trends in Global Market
    Table 2. P2X7 Receptor Antagonists Market Drivers in Global Market
    Table 3. P2X7 Receptor Antagonists Market Restraints in Global Market
    Table 4. Key Players of P2X7 Receptor Antagonists in Global Market
    Table 5. Top P2X7 Receptor Antagonists Players in Global Market, Ranking by Revenue (2021)
    Table 6. Global P2X7 Receptor Antagonists Revenue by Companies, (US$, Mn), 2017-2022
    Table 7. Global P2X7 Receptor Antagonists Revenue Share by Companies, 2017-2022
    Table 8. Global Companies P2X7 Receptor Antagonists Product Type
    Table 9. List of Global Tier 1 P2X7 Receptor Antagonists Companies, Revenue (US$, Mn) in 2021 and Market Share
    Table 10. List of Global Tier 2 and Tier 3 P2X7 Receptor Antagonists Companies, Revenue (US$, Mn) in 2021 and Market Share
    Table 11. By Type – Global P2X7 Receptor Antagonists Revenue, (US$, Mn), 2021 & 2028
    Table 12. By Type - P2X7 Receptor Antagonists Revenue in Global (US$, Mn), 2017-2022
    Table 13. By Type - P2X7 Receptor Antagonists Revenue in Global (US$, Mn), 2023-2028
    Table 14. By Application – Global P2X7 Receptor Antagonists Revenue, (US$, Mn), 2021 & 2028
    Table 15. By Application - P2X7 Receptor Antagonists Revenue in Global (US$, Mn), 2017-2022
    Table 16. By Application - P2X7 Receptor Antagonists Revenue in Global (US$, Mn), 2023-2028
    Table 17. By Region – Global P2X7 Receptor Antagonists Revenue, (US$, Mn), 2021 & 2028
    Table 18. By Region - Global P2X7 Receptor Antagonists Revenue (US$, Mn), 2017-2022
    Table 19. By Region - Global P2X7 Receptor Antagonists Revenue (US$, Mn), 2023-2028
    Table 20. By Country - North America P2X7 Receptor Antagonists Revenue, (US$, Mn), 2017-2022
    Table 21. By Country - North America P2X7 Receptor Antagonists Revenue, (US$, Mn), 2023-2028
    Table 22. By Country - Europe P2X7 Receptor Antagonists Revenue, (US$, Mn), 2017-2022
    Table 23. By Country - Europe P2X7 Receptor Antagonists Revenue, (US$, Mn), 2023-2028
    Table 24. By Region - Asia P2X7 Receptor Antagonists Revenue, (US$, Mn), 2017-2022
    Table 25. By Region - Asia P2X7 Receptor Antagonists Revenue, (US$, Mn), 2023-2028
    Table 26. By Country - South America P2X7 Receptor Antagonists Revenue, (US$, Mn), 2017-2022
    Table 27. By Country - South America P2X7 Receptor Antagonists Revenue, (US$, Mn), 2023-2028
    Table 28. By Country - Middle East & Africa P2X7 Receptor Antagonists Revenue, (US$, Mn), 2017-2022
    Table 29. By Country - Middle East & Africa P2X7 Receptor Antagonists Revenue, (US$, Mn), 2023-2028
    Table 30. GlaxoSmithKline Corporate Summary
    Table 31. GlaxoSmithKline P2X7 Receptor Antagonists Product Offerings
    Table 32. GlaxoSmithKline P2X7 Receptor Antagonists Revenue (US$, Mn), (2017-2022)
    Table 33. AstraZeneca Corporate Summary
    Table 34. AstraZeneca P2X7 Receptor Antagonists Product Offerings
    Table 35. AstraZeneca P2X7 Receptor Antagonists Revenue (US$, Mn), (2017-2022)
    Table 36. Janssen Corporate Summary
    Table 37. Janssen P2X7 Receptor Antagonists Product Offerings
    Table 38. Janssen P2X7 Receptor Antagonists Revenue (US$, Mn), (2017-2022)
    Table 39. RaQualia Pharma Corporate Summary
    Table 40. RaQualia Pharma P2X7 Receptor Antagonists Product Offerings
    Table 41. RaQualia Pharma P2X7 Receptor Antagonists Revenue (US$, Mn), (2017-2022)
    Table 42. Evotec Corporate Summary
    Table 43. Evotec P2X7 Receptor Antagonists Product Offerings
    Table 44. Evotec P2X7 Receptor Antagonists Revenue (US$, Mn), (2017-2022)
    Table 45. Asahi Kasei Pharma Corporate Summary
    Table 46. Asahi Kasei Pharma P2X7 Receptor Antagonists Product Offerings
    Table 47. Asahi Kasei Pharma P2X7 Receptor Antagonists Revenue (US$, Mn), (2017-2022)
    Table 48. Pfizer Corporate Summary
    Table 49. Pfizer P2X7 Receptor Antagonists Product Offerings
    Table 50. Pfizer P2X7 Receptor Antagonists Revenue (US$, Mn), (2017-2022)
List of Figures
    Figure 1. P2X7 Receptor Antagonists Segment by Type in 2021
    Figure 2. P2X7 Receptor Antagonists Segment by Application in 2021
    Figure 3. Global P2X7 Receptor Antagonists Market Overview: 2021
    Figure 4. Key Caveats
    Figure 5. Global P2X7 Receptor Antagonists Market Size: 2021 VS 2028 (US$, Mn)
    Figure 6. Global P2X7 Receptor Antagonists Revenue, 2017-2028 (US$, Mn)
    Figure 7. The Top 3 and 5 Players Market Share by P2X7 Receptor Antagonists Revenue in 2021
    Figure 8. By Type - Global P2X7 Receptor Antagonists Revenue Market Share, 2017-2028
    Figure 9. By Application - Global P2X7 Receptor Antagonists Revenue Market Share, 2017-2028
    Figure 10. By Region - Global P2X7 Receptor Antagonists Revenue Market Share, 2017-2028
    Figure 11. By Country - North America P2X7 Receptor Antagonists Revenue Market Share, 2017-2028
    Figure 12. US P2X7 Receptor Antagonists Revenue, (US$, Mn), 2017-2028
    Figure 13. Canada P2X7 Receptor Antagonists Revenue, (US$, Mn), 2017-2028
    Figure 14. Mexico P2X7 Receptor Antagonists Revenue, (US$, Mn), 2017-2028
    Figure 15. By Country - Europe P2X7 Receptor Antagonists Revenue Market Share, 2017-2028
    Figure 16. Germany P2X7 Receptor Antagonists Revenue, (US$, Mn), 2017-2028
    Figure 17. France P2X7 Receptor Antagonists Revenue, (US$, Mn), 2017-2028
    Figure 18. U.K. P2X7 Receptor Antagonists Revenue, (US$, Mn), 2017-2028
    Figure 19. Italy P2X7 Receptor Antagonists Revenue, (US$, Mn), 2017-2028
    Figure 20. Russia P2X7 Receptor Antagonists Revenue, (US$, Mn), 2017-2028
    Figure 21. Nordic Countries P2X7 Receptor Antagonists Revenue, (US$, Mn), 2017-2028
    Figure 22. Benelux P2X7 Receptor Antagonists Revenue, (US$, Mn), 2017-2028
    Figure 23. By Region - Asia P2X7 Receptor Antagonists Revenue Market Share, 2017-2028
    Figure 24. China P2X7 Receptor Antagonists Revenue, (US$, Mn), 2017-2028
    Figure 25. Japan P2X7 Receptor Antagonists Revenue, (US$, Mn), 2017-2028
    Figure 26. South Korea P2X7 Receptor Antagonists Revenue, (US$, Mn), 2017-2028
    Figure 27. Southeast Asia P2X7 Receptor Antagonists Revenue, (US$, Mn), 2017-2028
    Figure 28. India P2X7 Receptor Antagonists Revenue, (US$, Mn), 2017-2028
    Figure 29. By Country - South America P2X7 Receptor Antagonists Revenue Market Share, 2017-2028
    Figure 30. Brazil P2X7 Receptor Antagonists Revenue, (US$, Mn), 2017-2028
    Figure 31. Argentina P2X7 Receptor Antagonists Revenue, (US$, Mn), 2017-2028
    Figure 32. By Country - Middle East & Africa P2X7 Receptor Antagonists Revenue Market Share, 2017-2028
    Figure 33. Turkey P2X7 Receptor Antagonists Revenue, (US$, Mn), 2017-2028
    Figure 34. Israel P2X7 Receptor Antagonists Revenue, (US$, Mn), 2017-2028
    Figure 35. Saudi Arabia P2X7 Receptor Antagonists Revenue, (US$, Mn), 2017-2028
    Figure 36. UAE P2X7 Receptor Antagonists Revenue, (US$, Mn), 2017-2028
    Figure 37. GlaxoSmithKline P2X7 Receptor Antagonists Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 38. AstraZeneca P2X7 Receptor Antagonists Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 39. Janssen P2X7 Receptor Antagonists Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 40. RaQualia Pharma P2X7 Receptor Antagonists Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 41. Evotec P2X7 Receptor Antagonists Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 42. Asahi Kasei Pharma P2X7 Receptor Antagonists Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 43. Pfizer P2X7 Receptor Antagonists Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
63
Frequently Asked Questions
P2X7 Receptor Antagonists Market report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
P2X7 Receptor Antagonists Market report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
P2X7 Receptor Antagonists Market report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports